Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease

NCT03325322 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT03325322
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03325322 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Frailty, Inflammation, and Stem Cell Functionality in Chronic Kidney Disease
Lead sponsor
Mayo Clinic
Phase
Phase 2
Overall status
Suspended
Start date
January 2, 2018
Completion date
January 31, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, diabetes mellitus, diabetic nephropathies